This randomized, multicenter study compares 2 parallel groups of patients with migraine :
* I: patients are treated with relaxation + medical treatment (beta-bloquant or Oxetorone)+ patients' education
* II: patients are treated only with medical treatment + patients' education.
Visit 1 : 1 month before randomization for patient's selection and baseline data
Visit 2 (J0): inclusion (randomization) During the first 2 months patients from group I benefit from relaxation consultations.
Visit 3 (2 months after randomization)and visit 4 (4 months after randomization) : evaluation of the efficacy of the two treatment strategies.
Primary endpoint :
\- number of days with migraine per month from J0 to visit 4.
Secondary endpoints :
* monthly drug consumption
* percentage of patients who respond (50 % frequency reduction)
* quality of life (SF 36)
Each day, patients note in a notebook if a migraine appears and its intensity.
